Microfluidic enrichment of plasma cells improves treatment of multiple myeloma

Microfluidic enrichment of plasma cells improves treatment of multiple myeloma

Cytogenetic alterations form the basis for risk stratification for multiple myeloma (MM) and guide the selection of therapy; however, current pathology assays performed on bone marrow samples can produce false‐negatives due to the unpredictable distribution and rarity of MM cells. Here, we report on...

Full description

Bibliographic Details
Main Authors: Yunjing Zeng, Li Gao, Xiaoqing Luo, Yan Chen, Mustafa H. Kabeer, Xuelian Chen, Andres Stucky, William G. Loudon, Shengwen C. Li, Xi Zhang, Jiang F. Zhong
Format: Article
Language:English
Published: Wiley 2018-06-01
Series:Molecular Oncology
Subjects:
microfluidic
myeloma
risk stratification
Online Access:https://doi.org/10.1002/1878-0261.12201

Internet

https://doi.org/10.1002/1878-0261.12201

Similar Items